MR1 RESTRICTED T CELL RECEPTORS FOR CANCER IMMUNOTHERAPY Application EP-4273233-A3 European Patent Office 15 Nov 2023
MR1 restricted T cell receptors for cancer immunotherapy Grant US-11702459-B2 United States of America 18 Jul 2023
Salts of an LSD1 inhibitor and processes for preparing the same Grant US-11512064-B2 United States of America 29 Nov 2022